Last update 20 Mar 2025

Yohimbine Hydrochloride

Overview

Basic Info

Drug Type
Small molecule drug
Synonyms
(+)-yohimbine, (16α,17α)-17-hydroxyyohimban-16-carboxylic acid methyl ester, 17α-hydroxyyohimban-16α-carboxylic acid methyl ester
+ [4]
Action
antagonists
Mechanism
α-adrenergic receptor antagonists(Alpha adrenergic receptor antagonists)
Therapeutic Areas
Active Indication
Inactive Indication-
Originator Organization-
Active Organization-
Inactive Organization-
Drug Highest PhaseApproved
First Approval Date-
Regulation-
Login to view timeline

Structure/Sequence

Molecular FormulaC21H26N2O3
InChIKeyBLGXFZZNTVWLAY-SCYLSFHTSA-N
CAS Registry146-48-5
View All Structures (2)

External Link

R&D Status

10 top approved records.
Login
to view more data
IndicationCountry/LocationOrganizationDate
Erectile Dysfunction---
Login to view more data

Clinical Result

Indication
Phase
Evaluation
View All Results
Study
Phase
PopulationAnalyzed EnrollmentGroupResultsEvaluationPublication Date
Phase 2
26
Placebo
afxemxyoss(wplnvnjclc) = lgtscusucr vbaztxmpxe (tatxtmwcka, xixnbrzuli - syhxyzvcnb)
-
24 Feb 2017
Phase 3
40
sugar pill
(Sugar Pill)
pfqjgavzdb(sfzjwmvhtk) = tbbopdecyb saegeecjsu (kxjqrdypfb, bmgrlusrbk - yhedayzfme)
-
11 Nov 2013
Group Cognitive Behavioral Therapy+Yohimbine Hydrochloride
(Yohimbine Hydrochloride)
pfqjgavzdb(sfzjwmvhtk) = dlxqlhvwlt saegeecjsu (kxjqrdypfb, jnpetnnpkm - wkrllqcnvn)
Phase 2
37
cpieoxogbv(edvzshqjka) = ezfsrlicsn celcnmuyfm (wobrlqhgcq, ivrqvqwabe - qflzuabvzv)
-
03 Jul 2012
cpieoxogbv(edvzshqjka) = ykhyfrcece celcnmuyfm (wobrlqhgcq, yhoqrxaheo - imetuwcbop)
Not Applicable
-
twtsxvwnpv(mfkrpdcefk) = substantial increases in 50, but not 22, kHz USVs were recorded during reinstatement hxfmdxxxtx (ulbreveyjh )
-
16 Nov 2011
Phase 1
31
uedudcamtd(xdgohfrhhx) = xxzyvuuezw nxhbdsugok (gdmkmimxgx, 6 - 16)
-
01 Nov 2010
uedudcamtd(xdgohfrhhx) = qyxbwsfdxk nxhbdsugok (gdmkmimxgx, -5 to 5)
Not Applicable
-
escufvjvmn(zyerqcviiq) = voknfnbuul lnxjuyvcuw (ziypiuizvu )
-
15 Oct 2006
Login to view more data

Translational Medicine

Boost your research with our translational medicine data.
Boost your research with our translational medicine data.

Deal

Boost your decision using our deal data.
Boost your decision using our deal data.

Core Patent

Boost your research with our Core Patent data.
Boost your research with our Core Patent data.

Clinical Trial

Identify the latest clinical trials across global registries.
Identify the latest clinical trials across global registries.

Approval

Accelerate your research with the latest regulatory approval information.
Accelerate your research with the latest regulatory approval information.

Regulation

Understand key drug designations in just a few clicks with Synapse.
Understand key drug designations in just a few clicks with Synapse.
Chat with Hiro
Get started for free today!
Accelerate Strategic R&D decision making with Synapse, PatSnap’s AI-powered Connected Innovation Intelligence Platform Built for Life Sciences Professionals.
Start your data trial now!
Synapse data is also accessible to external entities via APIs or data packages. Empower better decisions with the latest in pharmaceutical intelligence.
Bio
Bio Sequences Search & Analysis
Sign up for free
Chemical
Chemical Structures Search & Analysis
Sign up for free